Newborn
Screening
Analysis Our molecular line screens for SMA, SCID and XLA by multiplex qPCR.
Run separately or as a single SCID + SMA + XLA reaction, directly from one dried blood spot. One punch, up to three actionable results.
spectrometry Our mass spectrometry line resolves clinically significant hemoglobin variants with MS/MS sensitivity. Sample multiplexing keeps throughput high for large-scale programmes.
LaCAR is a trusted partner that provides fast and accurate diagnostic solutions tailored to the specific needs of my laboratory. With their dedicated support and advanced technology, I have complete peace of mind knowing that I can rely on them to guide me every step of the way and optimise our diagnostic processes.
Beyond the assays: everything that turns a dried blood spot into a validated result - automated preparation, high-throughput punching and newborn screening data management.
Ready-to-use, pre-printed collection cards for dried blood spots, available in several formats and compatible with standard 903® and 226 filter paper.
Precise punchers isolate each dried blood spot disc ready for testing, and our automated workstations run, read and report your screening assays. From disc to result, with minimal hands-on time.
GeneFoxCub is our interpretation-support software for newborn screening. It turns raw analysis data into clear, standardised results. Helping your team interpret and review them easily and consistently.
Research and Development
Our visionAt LaCAR, we envision a world where everyone benefits from rapid and reliable genetic diagnostics, enabling personalised healthcare while contributing to more equitable and sustainable global public health.
Aware of these challenges, our R&D team is committed to meeting the needs of customers and patients, taking into account the specific recommendations of different countries and continents, as well as advances in academic research and technology.